Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay.

about

A Simple and Rapid Method for Quality Control of Major Histocompatibility Complex-Peptide Monomers by Flow Cytometry.Impact of curative radiotherapy on the immune status of patients with localized prostate cancer

P2860

Q42152748-ECA3D9CC-C48C-471B-9680-AD421BA47923 Q58564319-F2C75303-853B-4B7B-AD47-3F6C3BAEC9A8

P2860

Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay.

Item

http://www.wikidata.org/entity/Q39641905

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Validation of immunomonitoring ...... ptide multimer staining assay.

@en

Validation of immunomonitoring ...... ptide multimer staining assay.

@nl

type

Item

label

Validation of immunomonitoring ...... ptide multimer staining assay.

@en

Validation of immunomonitoring ...... ptide multimer staining assay.

@nl

prefLabel

Validation of immunomonitoring ...... ptide multimer staining assay.

@en

Validation of immunomonitoring ...... ptide multimer staining assay.

@nl

P1476

Validation of immunomonitoring ...... ptide multimer staining assay.

@en

P2093

Angelica Cazaly

http://www.w3.org/2001/XMLSchema#string

Barbara Schmid-Horch

http://www.w3.org/2001/XMLSchema#string

Elisa Rusch

http://www.w3.org/2001/XMLSchema#string

Karoline Laske

http://www.w3.org/2001/XMLSchema#string

P Anoop Chandran

http://www.w3.org/2001/XMLSchema#string

P2860

Standardization of cytokine flow cytometry assays

More tricks with tetramers: a practical guide to staining T cells with peptide-MHC multimers

Phenotypic analysis of antigen-specific T lymphocytes

Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.

Genetic basis for clinical response to CTLA-4 blockade in melanoma

Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium

Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)

Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.

Ex vivo analysis of human antigen-specific CD8+ T-cell responses: quality assessment of fluorescent HLA-A2 multimer and interferon-gamma ELISPOT assays for patient immune monitoring.

Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.

P31

scholarly article

P356

10.1002/CYTO.B.21397

http://www.w3.org/2001/XMLSchema#string

P50

Hans-Georg Rammensee

Christian H. Ottensmeier

Cécile Gouttefangeas

P577

2016-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27363684

http://www.w3.org/2001/XMLSchema#string

Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay.

about

P2860

P2860

Validation of immunomonitoring methods for application in clinical studies: The HLA-peptide multimer staining assay.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P31

P356

P50

P577

P698